Literature DB >> 11279105

Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins.

D J Mazur1, F W Perrino.   

Abstract

The excision of nucleotides from DNA 3' termini is an important step in DNA replication, repair, and recombination pathways to generate correctly base paired termini for subsequent processing. The mammalian TREX1 and TREX2 proteins contain potent 3'-->5' exonucleases capable of functioning in this capacity. To study the activities of these exonucleases we have developed strategies to express and purify the recombinant mouse Trex1 and human TREX2 proteins in Escherichia coli in quantities sufficient for biochemical characterization. The Trex1 and TREX2 proteins are homodimers that exhibit robust 3' excision activities with very similar preferred reaction conditions and preferences for specific DNA substrates. In a steady-state kinetic analysis, oligonucleotide substrates were used to measure 3' nucleotide excision by Trex1 and TREX2. The Michaelis constants derived from these data indicate similar apparent kcat values of 22 s(-1) for Trex1 and 16 s(-1) for TREX2 using single-stranded oligonucleotides. The apparent KM values of 19 nm for Trex1 and 190 nm for TREX2 suggest relatively high affinities for DNA for both Trex1 and TREX2. An exonuclease competition assay was designed using heparin as a nonsubstrate inhibitor with a series of partial duplex DNAs to delineate the substrate structure preferences for 3' nucleotide excision by Trex1 and TREX2. The catalytic properties of the TREX proteins suggest roles for these enzymes in the 3' end-trimming processes necessary for producing correctly base paired 3' termini.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279105     DOI: 10.1074/jbc.M100623200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.

Authors:  Clinton D Orebaugh; Jason M Fye; Scott Harvey; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.

Authors:  Suzanna L Bailey; Scott Harvey; Fred W Perrino; Thomas Hollis
Journal:  DNA Repair (Amst)       Date:  2011-11-08

Review 3.  The role of DNA exonucleases in protecting genome stability and their impact on ageing.

Authors:  Penelope A Mason; Lynne S Cox
Journal:  Age (Dordr)       Date:  2011-09-23

4.  RAD51 mutants cause replication defects and chromosomal instability.

Authors:  Tae Moon Kim; Jun Ho Ko; Lingchuan Hu; Sung-A Kim; Alexander J R Bishop; Jan Vijg; Cristina Montagna; Paul Hasty
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

5.  WRN exonuclease activity is blocked by DNA termini harboring 3' obstructive groups.

Authors:  Jeanine A Harrigan; Jinshui Fan; Jamil Momand; Fred W Perrino; Vilhelm A Bohr; David M Wilson
Journal:  Mech Ageing Dev       Date:  2006-12-20       Impact factor: 5.432

6.  A universal fluorescence-based toolkit for real-time quantification of DNA and RNA nuclease activity.

Authors:  Emily C Sheppard; Sally Rogers; Nicholas J Harmer; Richard Chahwan
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

Review 7.  Intracellular Nucleic Acid Detection in Autoimmunity.

Authors:  John T Crowl; Elizabeth E Gray; Kathleen Pestal; Hannah E Volkman; Daniel B Stetson
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

8.  An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome.

Authors:  Tilmann Bürckstümmer; Christoph Baumann; Stephan Blüml; Evelyn Dixit; Gerhard Dürnberger; Hannah Jahn; Melanie Planyavsky; Martin Bilban; Jacques Colinge; Keiryn L Bennett; Giulio Superti-Furga
Journal:  Nat Immunol       Date:  2009-01-21       Impact factor: 25.606

9.  Deregulated type I IFN response in TREX1-associated familial chilblain lupus.

Authors:  Katrin Peschke; Franziska Friebe; Nick Zimmermann; Tom Wahlicht; Tina Schumann; Martin Achleitner; Nicole Berndt; Hella Luksch; Rayk Behrendt; Min Ae Lee-Kirsch; Axel Roers; Claudia Günther
Journal:  J Invest Dermatol       Date:  2013-11-22       Impact factor: 8.551

10.  Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.

Authors:  Masashi Morita; Gordon Stamp; Peter Robins; Anna Dulic; Ian Rosewell; Geza Hrivnak; Graham Daly; Tomas Lindahl; Deborah E Barnes
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.